Shanghai MicroPort EP Medtech CoSHSE:688351 +3.97%85 EBITDA Margin % is 23.18% as of Mar. 2026, which is 163% above its 10-year median of 8.82. GuruFocus rates SHSE:688351 with a GF Score™ of 85/100 and a GF Value™ of ¥27.31 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Shanghai MicroPort EP Medtech Co ranks better than 60.95% on this metric.
Shanghai MicroPort EP Medtech Co (SHSE:688351) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Shanghai MicroPort EP Medtech Co EBITDA Margin % Related Terms
Shanghai MicroPort EP Medtech Co EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort EP Medtech Co EBITDA Margin % Chart
SHSE:688351 vs ABT, SYK, MDT: EBITDA Margin % Comparison
For the Medical Devices subindustry, Shanghai MicroPort EP Medtech Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicroPort EP Medtech Co EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort EP Medtech Co's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Shanghai MicroPort EP Medtech Co's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai MicroPort EP Medtech Co (SHSE:688351) has a EBITDA Margin % of 23.18% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai MicroPort EP Medtech Co and its competitors. This is 163% above median its historical median of 8.82. According to the industry distribution chart, Shanghai MicroPort EP Medtech Co ranks #319 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 39%.
Is Shanghai MicroPort EP Medtech Co's EBITDA Margin % too high?
Shanghai MicroPort EP Medtech Co's current EBITDA Margin % of 23.18% is 163% above median its 10-year median of 8.82. The Medical Devices & Instruments industry median EBITDA Margin % is 7.44. Shanghai MicroPort EP Medtech Co's value of 23.18% is 211.6% above this industry median. Based on the distribution chart, Shanghai MicroPort EP Medtech Co ranks #319 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai MicroPort EP Medtech Co has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort EP Medtech Co's EBITDA Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort EP Medtech Co ranks #319 out of 817 companies for EBITDA Margin %. This puts Shanghai MicroPort EP Medtech Co in the upper half of its industry. The industry median EBITDA Margin % is 7.44. Shanghai MicroPort EP Medtech Co's value of 23.18% is 211.6% above this benchmark. While the company's 10-year median is 8.82 vs. the industry median of 7.44, Shanghai MicroPort EP Medtech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai MicroPort EP Medtech Co's current EBITDA Margin % of 23.18% is 211.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shanghai MicroPort EP Medtech Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort EP Medtech Co's current EBITDA Margin % is 23.18%, which is 163% above median its own 10-year median of 8.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort EP Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort EP Medtech Co (SHSE:688351) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥27.31, compared to a current price of ¥22.28 — trading 18.4% below its estimated fair value. The current EBITDA Margin % is 23.18%, which is 163% above median its 10-year median of 8.82 and 211.6% above the Medical Devices & Instruments industry median of 7.44. Shanghai MicroPort EP Medtech Co's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shanghai MicroPort EP Medtech Co (SHSE:688351), the current EBITDA Margin % is 23.18% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicroPort EP Medtech Co (SHSE:688351) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicroPort EP Medtech Co stock appears to be undervalued.
The current stock price of ¥22.28 is trading 18.4% below its estimated GF Value™ of ¥27.31.
GuruFocus considers Shanghai MicroPort EP Medtech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688351:
EBITDA Margin %: 23.18% (163% above median its 10-year median of 8.82)
GF Value™: ¥27.31 vs. price of ¥22.28 (18.4% below fair value)
Industry Position: 211.6% above the Medical Devices & Instruments median (#319 of 817)
No single metric tells the full story. See the SHSE:688351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai MicroPort EP Medtech Co Business Description
Shanghai MicroPort EP Medtech Co Ltd is engaged in the research, development, production and sales of various medical devices and equipment related to cardiac electrophysiology interventional diagnosis and treatment.
85GF Score
Get the complete analysis for SHSE:688351
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688351 has been successfully added to your 
